Viridian Therapeutics, Inc.

VRDN · Healthcare · Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases

Viridian Therapeutics, Inc. (VRDN), in the Healthcare sector, has 3 disclosed filings on Paydirt over the trailing twelve months from 2 corporate insiders: 2 purchases and 1 sale. Filers took a median of 2 days from execution to disclosure, and the most recent trade was executed Aug 19 and filed Aug 21. The most active filer was Fairmount Funds Management LLC with 2 filings.

Add to watchlist

Filings, ttm

2 buys · 1 sell

Traders, ttm

2 insiders

Volume, ttmiDollar value disclosed in the window

$30.3M

estimated for Congress, as filed for insiders

Median delay

execution to disclosure

Last traded

Aug 19

Filed Aug 20

ADViAverage daily dollar volume

$49.3M

market data

Share price · 12M

$23.88 (+22.1%)

Adjusted for splits and dividends.

Volume by month

Buys $30.0M Sells $348K

Estimated for Congress, as filed for insiders · by filing month · past 24 months

Who filed

FL Fairmount Funds Management LLC Director 2 filings TB

Thomas W. Beetham Chief Operating Officer 1 filing SM

Stephen F. Mahoney President and CEO 1 filing JT

Jennifer Tousignant Chief Legal Officer 1 filing

Recent filings

Jennifer TousignantSALE Chief Legal Officer $348K
14,212 sh across 2 lots
Exec Aug 19
Filed Aug 20 · 8:05 PM ET Fairmount Funds Management LLCPURCHASE Director $20.0M
1,176,470 sh × $17.00
Exec May 11
Filed May 13 · 4:31 PM ET Fairmount Funds Management LLCPURCHASE Director $10.0M
454,545 sh × $22.00
Exec Oct 23 2025
Filed Oct 27 2025 · 4:30 PM ET Stephen F. MahoneyPURCHASE President and CEO $499K
21,400 sh × $23.33
Exec Sep 27 2024
Filed Sep 30 2024 · 5:30 PM ET Thomas W. BeethamPURCHASE Chief Operating Officer $117K
5,000 sh × $23.41
Exec Sep 27 2024
Filed Sep 30 2024 · 5:30 PM ET Fairmount Healthcare Fund II L.P.PURCHASE Director $30.0M
1,600,000 sh × $18.75
Exec Sep 13 2024
Filed Sep 17 2024 · 5:30 PM ET